Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Arrowhead Pharmaceuticals (ARWR) Receivables - Net (2016 - 2025)

Arrowhead Pharmaceuticals' Receivables - Net history spans 14 years, with the latest figure at $218.4 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 8634.16% year-over-year to $218.4 million; the TTM value through Dec 2025 reached $218.4 million, up 8634.16%, while the annual FY2025 figure was $6.8 million, N/A changed from the prior year.
  • Receivables - Net reached $218.4 million in Q4 2025 per ARWR's latest filing, up from $6.8 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $218.4 million in Q4 2025 to a low of $150000.0 in Q4 2021.
  • Average Receivables - Net over 5 years is $24.4 million, with a median of $2.4 million recorded in 2025.
  • Peak YoY movement for Receivables - Net: tumbled 98.33% in 2021, then skyrocketed 26278.67% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $150000.0 in 2021, then surged by 26278.67% to $39.6 million in 2022, then plummeted by 96.11% to $1.5 million in 2023, then surged by 62.44% to $2.5 million in 2024, then soared by 8634.16% to $218.4 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Receivables - Net are $218.4 million (Q4 2025), $6.8 million (Q3 2025), and $9.7 million (Q2 2025).